Article
Diagnostic and therapeutic ERβ, HER2, BRCA biomakers in the histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification.
Annals of diagnostic pathology - 1 Apr 2021
Zhong Lin, Zhang Chunfang, Jia Wenting, Zhang Pengxin
Abstract excerpt
Several studies revealed that non-small cell lung cancers (NSCLCs) frequently express ER, PR, HER2 and carry BRCA mutation. However, these markers in histological subtypes of lung adenocarcinoma have not been thoroughly investigated. We retrospectively evaluated a total of 640 lung adenocarcinoma samples for ERα, ERβ, PR and HER2 expression by immunohistochemistry and western-blotting, for EGFR and BRCA mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
